Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

376 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma.
Andrews PA, Jones JA, Varki NM, Howell SB. Andrews PA, et al. Among authors: howell sb. Cancer Commun. 1990;2(2):93-100. doi: 10.3727/095535490820874641. Cancer Commun. 1990. PMID: 2372473
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies.
Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Robbins KT, et al. Among authors: howell sb. Head Neck. 1992 Sep-Oct;14(5):364-71. doi: 10.1002/hed.2880140505. Head Neck. 1992. PMID: 1399569
Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha.
Isonishi S, Jekunen AP, Hom DK, Eastman A, Edelstein PS, Thiebaut FB, Christen RD, Howell SB. Isonishi S, et al. Among authors: howell sb. J Clin Invest. 1992 Oct;90(4):1436-42. doi: 10.1172/JCI116010. J Clin Invest. 1992. PMID: 1401076 Free PMC article.
Modulation of cisplatin resistance in human malignant melanoma cells.
McClay EF, Albright KD, Jones JA, Eastman A, Christen R, Howell SB. McClay EF, et al. Among authors: howell sb. Cancer Res. 1992 Dec 15;52(24):6790-6. Cancer Res. 1992. PMID: 1458467
Intraperitoneal therapy in the management of patients with ovarian cancer.
McClay EF, Howell SB. McClay EF, et al. Among authors: howell sb. Hematol Oncol Clin North Am. 1992 Aug;6(4):915-26. Hematol Oncol Clin North Am. 1992. PMID: 1500393 Review.
Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
Jekunen A, Vick J, Sanga R, Chan TC, Howell SB. Jekunen A, et al. Among authors: howell sb. Cancer Res. 1992 Jul 1;52(13):3566-71. Cancer Res. 1992. PMID: 1617625
Enhancement of the loss of multiple drug resistance by hydroxyurea.
Christen RD, Shalinsky DR, Howell SB. Christen RD, et al. Among authors: howell sb. Semin Oncol. 1992 Jun;19(3 Suppl 9):94-100. Semin Oncol. 1992. PMID: 1641661
Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.
Isonishi S, Hom DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo JS, Eastman A, Howell SB. Isonishi S, et al. Among authors: howell sb. Cancer Res. 1991 Nov 1;51(21):5903-9. Cancer Res. 1991. PMID: 1657373
Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.
Shalinsky DR, Slovak ML, Howell SB. Shalinsky DR, et al. Among authors: howell sb. Br J Cancer. 1991 Oct;64(4):705-9. doi: 10.1038/bjc.1991.385. Br J Cancer. 1991. PMID: 1680368 Free PMC article.
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells.
Mann SC, Andrews PA, Howell SB. Mann SC, et al. Among authors: howell sb. Int J Cancer. 1991 Jul 30;48(6):866-72. doi: 10.1002/ijc.2910480613. Int J Cancer. 1991. PMID: 1713575
376 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback